Products

Mitotax 100mg (Paclitaxel) Injection Mitotax 100mg Injection contains Paclitaxel, a widely used chemotherapy medicine used in the treatment of various types of cancers. It belongs to the taxane class of anticancer drugs, which work by stopping the growth and spread of cancer cells in the body. Paclitaxel injections are commonly administered in hospitals and oncology treatment centers under the supervision of qualified healthcare professionals. Ernest Oncology supplies Mitotax 100mg (Paclitaxel) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Mitotax Injection Generic Name: Paclitaxel Strength: 100mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Chemotherapy Medicine Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Mitotax 100mg Injection Mitotax (Paclitaxel) Injection is used in the treatment of: • Breast Cancer • Ovarian Cancer • Non-Small Cell Lung Cancer • Cervical Cancer • Kaposi’s Sarcoma • Other solid tumors It is often used in combination with other chemotherapy medicines for better treatment outcomes. How Mitotax Injection Works Paclitaxel works by stabilizing microtubules inside cancer cells, preventing them from dividing and multiplying. This helps slow down or stop the growth of cancer cells. Administration Mitotax 100mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall health condition The medicine is administered intravenously in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Hair loss • Fatigue • Low blood cell counts • Numbness or tingling in hands and feet • Increased risk of infection Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Lippod 20mg (Doxorubicin Liposomal) Injection Lippod 20mg Injection contains Doxorubicin Liposomal, a chemotherapy medicine used in the treatment of several types of cancers. The liposomal formulation improves drug delivery to tumor cells while reducing damage to healthy tissues. Doxorubicin liposomal injections are widely used in oncology treatment protocols and are administered under the supervision of qualified healthcare professionals in hospitals or specialized cancer treatment centers. Ernest Oncology supplies Lippod 20mg (Doxorubicin Liposomal) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Lippod Injection Generic Name: Doxorubicin (Liposomal) Strength: 20mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Chemotherapy Medicine Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Lippod 20mg Injection Lippod (Doxorubicin Liposomal) Injection is used in the treatment of: • Ovarian Cancer • Breast Cancer • Multiple Myeloma • Kaposi’s Sarcoma • Other solid tumors It is commonly used as part of combination chemotherapy therapy for improved treatment results. How Lippod Injection Works Doxorubicin works by interfering with the DNA of cancer cells, preventing them from growing and dividing. The liposomal formulation helps the drug circulate longer in the bloodstream and target cancer cells more effectively. Administration Lippod 20mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall health condition The medicine is administered intravenously in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Hair loss • Fatigue • Low blood cell counts • Mouth sores • Skin reactions Patients should consult their healthcare provider if symptoms persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpext.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Myezom 2mg (Bortezomib) Injection Myezom 2mg Injection contains Bortezomib, a targeted anticancer medicine used in the treatment of certain blood cancers such as Multiple Myeloma and Mantle Cell Lymphoma. It belongs to a class of medicines known as proteasome inhibitors, which help slow down or stop the growth of cancer cells. Bortezomib injections are widely used in oncology treatment protocols and are administered under the supervision of qualified healthcare professionals in hospitals or specialized cancer treatment centers. Ernest Oncology supplies Myezom 2 mg (Bortezomib) Injection globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Myezom Injection Generic Name: Bortezomib Strength: 2 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Proteasome Inhibitor Packaging Type: Vial Route of Administration: Intravenous (IV) / Subcutaneous Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Myezom 2 mg Injection Myezom (Bortezomib) Injection is used in the treatment of: • Multiple Myeloma • Mantle Cell Lymphoma It is often used as part of combination chemotherapy therapy to improve treatment outcomes. How Myezom Injection Works Bortezomib works by blocking the proteasome, a protein complex that breaks down damaged proteins in cells. By inhibiting this process, the medicine causes cancer cells to accumulate abnormal proteins, leading to their death and slowing tumor growth. Administration Myezom 2mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall medical condition The medicine may be given intravenously or subcutaneously in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Fatigue • Nausea • Diarrhea • Low blood cell counts • Peripheral neuropathy (tingling or numbness in hands and feet) • Fever Patients should consult their healthcare provider if symptoms persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Pamorelin LA 3.75mg (Triptorelin) Injection Pamorelin LA 3.75 mg Injection contains Triptorelin, a synthetic hormone that belongs to the class of GnRH (Gonadotropin-Releasing Hormone) agonists. It is widely used in the treatment of hormone-dependent cancers and reproductive disorders by reducing the production of certain hormones in the body. Triptorelin injections are commonly used in oncology and hormonal therapy treatments and must be administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Pamorelin LA 3.75mg (Triptorelin) Injection worldwide with safe packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Pamorelin LA Injection Generic Name: Triptorelin Strength: 3.75mg Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Packaging Type: Depot Injection / Vial Route of Administration: Intramuscular Injection Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Pamorelin LA 3.75mg Injection Pamorelin LA (Triptorelin) Injection is used for the treatment of: • Prostate Cancer • Endometriosis • Uterine Fibroids • Precocious Puberty • Hormone-dependent cancers It helps regulate hormone levels that influence the growth of certain cancers and hormonal disorders. How Pamorelin LA Injection Works Triptorelin works by acting on the pituitary gland to suppress the production of sex hormones such as testosterone and estrogen. Lower hormone levels help slow or stop the growth of hormone-dependent cancer cells. Administration Pamorelin LA 3.75 mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s medical condition • Treatment protocol • Doctor’s recommendation The medicine is usually given as a long-acting depot injection in hospitals or specialized medical centers. Possible Side Effects Some patients may experience: • Hot flashes • Headache • Fatigue • Mood changes • Injection site reactions • Decreased libido Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from direct sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Lippod 50mg (Doxorubicin Liposomal) Injection Lippod 50mg Injection contains Doxorubicin Liposomal, a chemotherapy medicine used in the treatment of several types of cancers. The liposomal formulation helps deliver the drug more effectively to cancer cells while reducing damage to healthy tissues. Doxorubicin liposomal injections are widely used in oncology treatment protocols and are administered under the supervision of qualified healthcare professionals in hospitals or specialized cancer treatment centers. Ernest Oncology supplies Lippod 50mg (Doxorubicin Liposomal) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Lippod Injection Generic Name: Doxorubicin (Liposomal) Strength: 50mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Chemotherapy Medicine Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Lippod 50mg Injection Lippod (Doxorubicin Liposomal) Injection is used in the treatment of: • Ovarian Cancer • Breast Cancer • Multiple Myeloma • Kaposi’s Sarcoma • Other solid tumors It is often used as part of combination chemotherapy therapy to improve treatment outcomes. How Lippod Injection Works Doxorubicin works by interfering with the DNA of cancer cells, preventing them from growing and dividing. The liposomal formulation allows the drug to circulate longer in the bloodstream and target tumor cells more effectively. Administration Lippod 50mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type and stage of cancer • Treatment protocol • Patient’s overall health condition The medicine is administered intravenously in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Nausea and vomiting • Hair loss • Fatigue • Low blood cell counts • Mouth sores • Skin reactions Patients should consult their healthcare provider if symptoms persist or worsen. Storage Instructions • Store below 25°C • Protect from light • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier 🌐 Websites www.ernestpharmaceuticals.com www.oncologymedicinesupplier.com www.oncology.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Pamorelin LA 11.25mg (Triptorelin) Injection Pamorelin LA 11.25 mg Injection contains Triptorelin, a synthetic hormone belonging to the class of GnRH (Gonadotropin-Releasing Hormone) agonists. It is widely used in the treatment of hormone-dependent cancers and reproductive disorders by reducing the production of certain hormones in the body. Triptorelin injections are commonly used in oncology and hormonal therapy treatments and must be administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Pamorelin LA 11.25mg (Triptorelin) Injection worldwide with safe packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Pamorelin LA Injection Generic Name: Triptorelin Strength: 11.25mg Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Packaging Type: Depot Injection / Vial Route of Administration: Intramuscular Injection Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Pamorelin LA 11.25mg Injection Pamorelin LA (Triptorelin) Injection is used in the treatment of: • Prostate Cancer • Hormone-dependent cancers • Endometriosis • Uterine Fibroids • Precocious Puberty It helps regulate hormone levels that influence the growth of certain cancers and hormonal disorders. How Pamorelin LA Injection Works Triptorelin works by acting on the pituitary gland to suppress the production of sex hormones such as testosterone and estrogen. Lower hormone levels help slow or stop the growth of hormone-dependent cancer cells. Administration Pamorelin LA 11.25 mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s medical condition • Treatment protocol • Doctor’s recommendation The medicine is typically given as a long-acting depot injection in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Hot flashes • Headache • Fatigue • Mood changes • Injection site reactions • Decreased libido Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from direct sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Pamorelin LA 22.5mg (Triptorelin) Injection Pamorelin LA 22.5 mg Injection contains Triptorelin, a synthetic hormone belonging to the class of GnRH (Gonadotropin-Releasing Hormone) agonists. It is widely used in the treatment of hormone-dependent cancers and reproductive disorders by reducing the production of certain hormones in the body. Triptorelin injections are commonly used in oncology and hormonal therapy treatments and are administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Pamorelin LA 22.5 mg (Triptorelin) Injection globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Pamorelin LA Injection Generic Name: Triptorelin Strength: 22.5mg Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Packaging Type: Depot Injection / Vial Route of Administration: Intramuscular Injection Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Pamorelin LA 22.5mg Injection Pamorelin LA (Triptorelin) Injection is used for the treatment of: • Prostate Cancer • Hormone-dependent cancers • Endometriosis • Uterine Fibroids • Precocious Puberty It helps regulate hormone levels that influence the growth of certain cancers and hormonal disorders. How Pamorelin LA Injection Works Triptorelin works by acting on the pituitary gland to suppress the production of sex hormones such as testosterone and estrogen. Lower hormone levels help slow or stop the growth of hormone-dependent cancer cells. Administration Pamorelin LA 22.5 mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s medical condition • Treatment protocol • Doctor’s recommendation The medicine is typically given as a long-acting depot injection in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Hot flashes • Headache • Fatigue • Mood changes • Injection site reactions • Decreased libido Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from direct sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Luprova 22.5mg (Leuprolide) Injection Luprova 22.5 mg Injection contains Leuprolide, a synthetic hormone belonging to the class of GnRH (Gonadotropin-Releasing Hormone) agonists. It is widely used in the treatment of hormone-dependent cancers and reproductive disorders by reducing the production of certain hormones in the body. Leuprolide injections are commonly used in oncology and hormonal therapy treatments and must be administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Luprova 22.5mg (Leuprolide) Injection globally with safe packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Luprova Injection Generic Name: Leuprolide Strength: 22.5mg Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Packaging Type: Vial / Depot Injection Route of Administration: Intramuscular / Subcutaneous Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Luprova 22.5mg Injection Luprova (Leuprolide) Injection is used in the treatment of: • Prostate Cancer • Breast Cancer • Endometriosis • Uterine Fibroids • Precocious Puberty It helps control hormone levels that influence the growth of hormone-dependent cancers. How Luprova Injection Works Leuprolide works by acting on the pituitary gland to decrease the production of sex hormones such as testosterone and estrogen. Lower hormone levels help slow or stop the growth of hormone-dependent cancer cells. Administration Luprova 22.5mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s medical condition • Treatment protocol • Doctor’s recommendation The medicine is usually given as a long-acting depot injection in hospitals or oncology treatment centers. Possible Side Effects Some patients may experience: • Hot flashes • Headache • Fatigue • Mood changes • Injection site reactions • Decreased libido Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from direct sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Luprova 11.25mg (Leuprolide) Injection Luprova 11.25 mg Injection contains Leuprolide, a synthetic hormone belonging to the class of GnRH (Gonadotropin-Releasing Hormone) agonists. It is widely used for the treatment of hormone-dependent cancers and reproductive disorders by reducing the production of certain hormones in the body. Leuprolide injections are commonly used in oncology and hormonal therapy treatments and should be administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Luprova 11.25mg (Leuprolide) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Luprova Injection Generic Name: Leuprolide Strength: 11.25mg Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Packaging Type: Vial / Depot Injection Route of Administration: Intramuscular / Subcutaneous Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Luprova 11.25mg Injection Luprova (Leuprolide) Injection is used for the treatment of: • Prostate Cancer • Breast Cancer • Endometriosis • Uterine Fibroids • Precocious Puberty (early puberty) It helps control hormone levels that influence the growth of certain cancers and hormone-related conditions. How Luprova Injection Works Leuprolide works by acting on the pituitary gland to reduce the production of sex hormones such as testosterone and estrogen. Lower hormone levels help slow down or stop the growth of hormone-dependent cancer cells. Administration Luprova 11.25 mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s medical condition • Treatment protocol • Doctor’s recommendation The injection is typically administered as a long-acting depot injection in hospitals or specialized medical centers. Possible Side Effects Some patients may experience: • Hot flashes • Headache • Mood changes • Fatigue • Injection site reactions • Decreased libido Patients should consult their healthcare provider if symptoms persist or worsen. Storage Instructions • Store below 25°C • Protect from direct sunlight • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Pegfeel 6 mg (Pegfilgrastim) Injection Pegfeel 6 mg Injection contains Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF) used to reduce the risk of infection in patients receiving chemotherapy. It helps the body produce more white blood cells, which are essential for fighting infections. Pegfilgrastim injections are widely used as supportive care in cancer treatment to manage chemotherapy-induced neutropenia. The medicine is administered under the supervision of qualified healthcare professionals. Ernest Oncology supplies Pegfeel 6 mg (Pegfilgrastim) Injection globally with safe packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Pegfeel Injection Generic Name: Pegfilgrastim Strength: 6 mg Dosage Form: Injection Therapeutic Class: Hematopoietic Agent / G-CSF Packaging Type: Prefilled Syringe/Vial Route of Administration: Subcutaneous Injection Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Pegfeel 6 mg Injection Pegfeel (Pegfilgrastim) Injection is used for: • Prevention of chemotherapy-induced neutropenia • Reducing infection risk in cancer patients • Supporting white blood cell production during chemotherapy • Improving immune recovery after cancer treatment It is commonly used as part of supportive care therapy in oncology. How Pegfeel Injection Works Pegfilgrastim works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell that helps fight infections. By increasing neutrophil counts, the medicine reduces the risk of infections during chemotherapy treatment. Administration Pegfeel 6 mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Chemotherapy treatment schedule • Patient’s medical condition • Doctor’s recommendation It is usually given as a single subcutaneous injection after chemotherapy cycles. Possible Side Effects Some patients may experience: • Bone pain • Muscle pain • Headache • Fatigue • Nausea • Injection site reactions Patients should consult their healthcare provider if symptoms persist or worsen. Storage Instructions • Store at 2°C – 8°C (Refrigerated) • Do not freeze • Protect from light • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Reditux 100mg (Rituximab) Injection Reditux 100mg Injection contains Rituximab, a monoclonal antibody used in the treatment of certain cancers and autoimmune diseases. It works by targeting specific proteins on the surface of abnormal B-cells, helping the immune system destroy these cells. Rituximab injections are widely used in modern oncology and immunology treatments and are administered under the supervision of qualified healthcare professionals in hospitals or specialized medical centers. Ernest Oncology supplies Reditux 100mg (Rituximab) Injection worldwide with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Reditux Injection Generic Name: Rituximab Strength: 100mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging Type: Vial Route of Administration: Intravenous (IV) Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Reditux 100mg Injection Reditux (Rituximab) Injection is used in the treatment of: • Non-Hodgkin’s Lymphoma (NHL) • Chronic Lymphocytic Leukemia (CLL) • Rheumatoid Arthritis • Certain autoimmune disorders It helps improve treatment outcomes by targeting abnormal B-cells responsible for disease progression. How Reditux Injection Works Rituximab works by binding to the CD20 protein found on B-lymphocytes (a type of white blood cell). This action helps the immune system identify and destroy abnormal or cancerous B-cells, slowing disease progression. Administration Reditux 100mg Injection should only be administered by a qualified healthcare professional. Dosage depends on: • Patient’s body weight • Type of disease being treated • Treatment protocol • Patient’s overall medical condition The medicine is administered intravenously in hospitals or specialized treatment centers. Possible Side Effects Some patients may experience: • Fever and chills • Fatigue • Nausea • Headache • Low blood cell counts • Infusion-related reactions Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Protect from direct sunlight • Keep in a cool and dry place • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Abstet 250mg (Abiraterone Acetate) Tablet Abstet 250 mg Tablet contains Abiraterone Acetate, a targeted anticancer medicine used in the treatment of prostate cancer. It works by reducing the production of certain hormones in the body that help prostate cancer grow. This medicine is commonly prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC) and is usually used in combination with other medications as part of a comprehensive treatment plan. Ernest Oncology supplies Abstet 250mg (Abiraterone Acetate) Tablets globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Abstet Tablet Generic Name: Abiraterone Acetate Strength: 250mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer/Hormone Therapy Packaging Type: Tablet Strip / Box Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Abstet 250mg Tablet Abstet (Abiraterone Acetate) Tablet is used in the treatment of: • Metastatic Prostate Cancer • Castration-Resistant Prostate Cancer • Advanced Prostate Cancer It helps slow the progression of prostate cancer by lowering androgen hormone levels in the body. How Abstet Tablet Works Abiraterone works by blocking the CYP17 enzyme, which plays an important role in the production of androgens (male hormones). By reducing androgen levels, the medicine helps slow or stop the growth of prostate cancer cells. Administration Abstet 250 mg The tablet should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • On an empty stomach • Swallowed whole with water Dosage and duration depend on the patient’s medical condition and treatment plan. Possible Side Effects Some patients may experience: • Fatigue • Joint pain • High blood pressure • Fluid retention • Low potassium levels • Nausea Patients should consult their doctor if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383